Thus, these data suggest that CD46 expression could be a key factor of MV selectivity to melanoma cells comparing with non-malignant cells; however, other factors should also be implicated into the different sensitivity of the melanoma cells as it cannot be explained only by different levels of CD46 expression. Here, CD46 is linked to melanoma.